Lupin’s impotence drug gets initial USFDA nod
Drug firm Lupin on Thursday said it has received tentative approval from the U.S. health regulator for its Tadalafil tablets, indicated for treating erectile dysfunction and prostate gland enlargement.
The United States Food and Drug Administration (USFDA) clearance is for marketing Tadalafil tablets in strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg, in the U.S., Lupin said. The product is a generic version of Eli Lilly and the company’s Cialis tablets.PTI
Source: Read Full Article
